Hello! I'm Samantha.
I am a health services and health policy researcher applying mixed-methods to understand the organization and delivery of mental health and substance use treatment and harm reduction services. Broadly, my work focuses on the accessibility and quality of substance use treatment and harm reduction services and the local, state, and federal policies that shape service access. I have special interest in aging and health, opioid use disorder, alcohol use disorder, and Medicare and Medicaid policy.
​
I am currently an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health working with the Bloomberg Overdose Prevention Initiative led by Dr. Brendan Saloner and Dr. Sachini Bandara. The Bloomberg Overdose Prevention Initiative, funded by Bloomberg Philanthropies, is a collaborative partnership with the Johns Hopkins Bloomberg School of Public Health Evaluation Team, Vital Strategies, The Pew Charitable Trust, and the CDC Foundation.
Samantha J Harris, PhD, MPA
Assistant Scientist
Johns Hopkins Bloomberg School of Public Health
Department of Health Policy and Management
Email:
Curriculum Vitae:
EDUCATION & TRAINING
2021 - 2023
POSTDOCTORAL TRAINING
Johns Hopkins University | Bloomberg School of Public Health
2016 - 2021
DOCTOR OF PHILOSOPHY
University of Georgia | School of Public and International Affairs
Specialization: Health Policy
2014 - 2016
MASTER OF PUBLIC ADMINISTRATION
University of Kentucky | Martin School of Public Policy and Administration
Specialization: Health Policy
2009 - 2014
BACHELOR OF ARTS WITH HONORS
University of Kentucky | College of Fine Arts and College of Arts & Sciences
Major: Arts Administration
Minors: Art History & English
LATEST PUBLICATION
SELECT PUBLICATIONS
Selected Journal Articles
See CV for a complete list
​
Harris SJ, Yarbrough CR, & Abraham AJ (2023). Changes in County-level Access to Medications for Opioid Use Disorder following Medicare-coverage of Methadone Treatment. Health Affairs. Published online July 5, 2023. doi:10.1377/hlthaff.2023.00148
​
Harris SJ (co-first), Feder KA (co-first), Byrne L, Miller SM, Sodder S, Berman V, Livingston A, Edwards J, Hartman S, Sugarman OK, Shah H, Xu J, Raikes J, Gattine S, Saloner B. Attitudes and beliefs about Vermont’s 2021 buprenorphine decriminalization law among residents who use illicit opioids. Drug and Alcohol Dependence. In press. doi.org/10.1016/j.drugalcdep.2023.110879
​
Harris SJ, Abraham AJ, Lozano-Rojas F, Negaro S, Andrews CM, & Grogan CM (2023). Allocation of Federal Funding to Address the Opioid Crisis in the Criminal Legal System. Journal of Substance Use and Addiction Treatment. Published online May 6, 2023. doi:10.1016/j.josat.2023.209064
​
Harris SJ (2023). An Early Implementation Analysis of Syringe Services Programs in Kentucky: Barriers and Facilitators Identified by Program Operators and Local Officials. AIDS and Behavior, 27(4), 1248-1258. doi: 10.1007/s10461-022-03861-9
​
Harris SJ, Abraham AJ, Yarbrough CR (2022). Availability of Medications for Alcohol Use Disorder Treatment in Medicare Part D, 2014-2018. Journal of Studies on Alcohol and Drugs, 83(5), 653-661. doi: 10.15288/jsad.21-00411
​​​
Harris SJ, Abraham AJ, Andrews CM, & Yarbrough CR (2020). Gaps in Access to Opioid Use Disorder Treatment for Medicare Beneficiaries: An Analysis of the Availability of Evidence-based, FDA-approved Medication for Opioid Use Disorder Treatment for the Nation’s Medicare Population. Health Affairs, 39(2), 233-237. doi: 10.1377/hlthaff.2019.00309
REPORTS
BLOG POSTS
